🇺🇸 FDA
Patent

US 9517224

Methods of treating patients infected with HIV and HTLV

granted A61KA61K31/35A61K31/352

Quick answer

US patent 9517224 (Methods of treating patients infected with HIV and HTLV) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/35, A61K31/352, A61K45/06, A61P